BIO is Confident in Regulatory System for Plant Biotech Products
The report makes some minor recommendations on how the U.S. Department of Agriculture (USDA), U.S. Food and Drug Administration (FDA), and U.S. Environmental Protection Agency (EPA) can better coordinate their efforts regarding the regulation of genetically engineered crops.
Sharon Bomer Lauritsen, executive vice president, food and agriculture for the Biotechnology Industry Organization (BIO), issued the following statement in response to the report:
“The Biotechnology Industry Organization and its member companies are confident in the rigorous testing and approval regimes of biotech products put in place by U.S. government authorities.
"While we are still reviewing the 109-page report, it appears that the GAO has suggested a small number of recommendations that could improve an already robust system. However, GAO is ignoring the fact that the three agencies working together have approved for commercial use dozens of crops that have been safely developed, tested and commercialized for the marketplace.
“The regulatory system works now as evidenced by dozens of safe, healthful products on the market as developed under stringent government oversight. Therefore, GAO’s recommendation for new monitoring of these safe products is unnecessary and not a prudent use of limited government resources. The regulatory process for genetically engineered crops as it exists represents two decades of safe use with absolutely no evidence of any health concerns.
“The U.S. biotechnology industry supports a science-based regulatory process requiring that biotech crops undergo intense regulatory scrutiny from the research lab, to field trials, to commercial plantings by farmers. The existing regulatory regime ensures the products we develop for use as food, feed, fiber or fuel are as safe as they are beneficial.”
Upcoming BIO Events
BIO-Asia Partnering Conference 2009
January 19-20, 2009
Tokyo, Japan
BIO CEO & Investor Conference 2009
February 9-10, 2009
New York, New York
BIO-Europe Spring
March 16-18, 2009
Milan, Italy
BIO Windhover 2009
April 13-15, 2009
New York, New York
2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.
BioEquity Europe
June 9-10, 2009
Munich, Germany
World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###